Blood a-synuclein aggregation assay as a novel diagnostic tool for parkinson's disease

The Defense Health Agency awarded a $365,623 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, a non-profit biomedical research organization in Barcelona, Spain. The grant, awarded on September 1, 2024, will support the development of a novel blood-based diagnostic test to detect alpha-synuclein aggregation as an indicator of Parkinson's disease. The organization has a history of receiving federal grant awards and conducting advanced medical research, including several sub-awards with prominent U.S. research institutions on topics such as mitochondrial protein interactions, Alzheimer's disease prevention, and brain circuit functions. This project grant aligns with the Military Medical Research and Development program's focus on transforming healthcare through innovative biomedical research, particularly for conditions relevant to military personnel and the broader public.